P

Perth Blood Institute | Perth, Australia

Research site

(Unclaimed)

Location

18 Prowse Street, Perth, Western Australia, Australia

Site insights

Top conditions

Top treatments

Lenalidomide

Dalteparin

Apixaban

Dexamethasone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 3 total trials

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

The purpose of this study is to compare the pharmacokinetic (PK) similarity, safety, tolerability, immunogenicity, and efficacy of HLX15-SC versus US...

Enrolling

Multiple Myeloma (MM)

Drug: HLX15-SC-Rd

Drug: US-DARZALEX FASPRO®-Rd

Trial sponsors

A

H

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms